CCEL

#4178
Cryo-Cell International, Inc. Common Stock
3.4 2 USD
+10018.34%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.97
3.42
Year Range
0.03
4.02
Daily Change
+10018.34%
Monthly Change
-2.43%
6 month change
+3.64%
Year Change
+3.64%
Previous Close
0.0 3
Open
3.1 0
Low
2.9 7
High
3.4 2
Volume
5
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 27.55 M
  • Employee 76
  • Founded 1989
  • CEO Mark L. Portnoy | David I. Portnoy
  • Website www.cryo-cell.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS6ZT0
  • Industry Medical Care Facilities
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-10.25
Price to sales ratio
0.87
Dividends per share
—
Dividend yield %
—

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

News